Biocon Share Price

ABOUT Biocon

• Industry Biotechnology & Drugs
• ISIN INE376G01013
• BSE Code 532523
• NSE Code BIOCON

Biocon Limited is an India-based biopharmaceutical company, engaged in the manufacture of biotechnology products and research services. The Company is in the business of manufacturing active pharmaceutical ingredients (APIs) and formulations, including biosimilar drugs for diabetics, oncology and autoimmune diseases. The Company’s segment includes Generics, Biosimilars, Novel Biologics and Research Services. It focuses on three key therapeutic areas - Diabetes, Oncology and Immunology. Its APIs pipeline includes cardiovascular, anti-diabetics, immunosuppressants, and specialty molecules. Its products include Tacrolimus, Rosuvastatin, Simvastatin, Atorvastatin, Pravastatin, Fingolimod and others. Its APIs manufacturing facilities with capabilities in microbial fermentation, downstream process, including chromatographic purification, chemical synthesis, peptide synthesis and Highly Potent APIs (HPAPIs). It has over five facilities in Bangalore, Hyderabad and Visakhapatnam in India.

MANAGEMENT

• Kiran Mazumdarshaw Executive Chairperson of the Board
• Siddharth Mittal Chief Executive Officer, Managing Director, Executive Director
• Mukesh Kamath Interim Chief Financial Officer
• Peter Bains Group Chief Executive Officer
• Shreehas Tambe Chief Executive Officer, Managing Director - Biocon Biologics Limited
• Arun Gupta Chief Operating Officer
• Manoj Pananchukunnath Chief Scientific Officer
• Mayank Verma Compliance Officer, Company Secretary
• Amit Kaptain Head - Commercial API
• Vishal Nayyar Head - Supply Chain Management